A

Arkansas Children's | Arkansas Children's Hospital - Arkansas Children's Research Institute - Neurology Department

Research site

(Unclaimed)

Location

1 Children's Way Slot 846, Little Rock, Arkansas, United States of America

Site insights

Top conditions

Top treatments

Lasmiditan

LY573144

DEX

Udenafil

AOC 1044

RPT904

Dexmedetomidine

Etrasimod

Pamrevlumab

Parent organization

This site is a part of Arkansas Children's

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely ac...

Enrolling

Ulcerative Colitis

Drug: Etrasimod

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2 (FUEL-2)

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...

Enrolling

Single Ventricle Heart Disease

Drug: Placebo

Drug: Udenafil

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy: This is a Phase 2b randomized, double-blind, placebo-controll...

Enrolling

Ig-E Mediated Food Allergy

Other: Placebo

Drug: RPT904

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

The study will evaluate the safety and efficacy of gene therapy in boys with DMD. It is a randomized, double-blind, placebo-controlled study with two...

Active, not recruiting

Duchenne Muscular Dystrophy

Other: Placebo

Genetic: PF-06939926